HYTN anticipates the arrival of the initial cultivation batches for GMP processing in Q2 2025, with the first shipments to Germany expected in late Q2 2025. 1. Johnny Green, "Legal Medical Cannabis ...

We think SPH is in a good financial position. In the past three years, its debt over capital has been stable at around 0.4 times. Despite not being in a net cash position, it has enough cash to ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased $443.8 thousand from ($221 thousand) to $222.8 ...

Chinese auto producers are looking to boost sales in Europe while their domestic market slows down, counting on their ...